Moleculin Biotech, Inc.
MBRX
$0.5748
$0.00721.27%
NASDAQ
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -15.58% | 14.84% | |||
| Depreciation & Amortization | -6.45% | 0.00% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -3.75% | -10.54% | |||
| Operating Income | 3.75% | 10.54% | |||
| Income Before Tax | -18.71% | -241.98% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -18.71% | -241.98% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -18.71% | -241.98% | |||
| EBIT | 3.75% | 10.54% | |||
| EBITDA | 3.72% | 10.59% | |||
| EPS Basic | 28.56% | -84.42% | |||
| Normalized Basic EPS | 28.57% | -84.45% | |||
| EPS Diluted | 28.56% | -84.42% | |||
| Normalized Diluted EPS | 28.57% | -84.45% | |||
| Average Basic Shares Outstanding | 66.17% | 85.41% | |||
| Average Diluted Shares Outstanding | 66.17% | 85.41% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||